Cleared Traditional

K812932 - ANERIOD GAUZE

K812932 is the FDA 510(k) clearance for ANERIOD GAUZE by Abco Dealers, Inc.. It is a Class 2 Cardiovascular device (product code DXG) cleared through the Traditional 510(k) pathway after a 43-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1981
Decision
43d
Days
Class 2
Risk

K812932 is an FDA 510(k) clearance for the ANERIOD GAUZE. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Abco Dealers, Inc. (Walker, US). The FDA issued a Cleared decision on December 2, 1981 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abco Dealers, Inc. devices

Submission Details

510(k) Number K812932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 1981
Decision Date December 02, 1981
Days to Decision 43 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 125d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 77
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K812932.
MODEL 78554A DATA MGMT. PLUG-IN MODULE
K822877 · Hewlett-Packard Co. · Oct 1982
CARDIO REVUE CENTER
K820820 · Diasonics, Inc. · Apr 1982
MODEL 4200 ELLESTAD STRESS TEST ANALYZER
K813222 · Del Mar Avionics · Dec 1981
SORENSON THERMODILUTION CARDIAC COMPUT
K812757 · Sorensen Research · Nov 1981
CARDIAC REVIEW STATION
K812515 · Diasonics, Inc. · Oct 1981
BAIM CORONARY SINUS FLOW ANALYZER
K811414 · Electro-Catheter Corp. · Jun 1981